Fear of cancer recurrence and its predictors among cervical cancer survivors

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20160805001

Enrollment

700

Registered

2016-08-05

Start date

2016-08-04

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical cancer survivors fear of progression

Interventions

Cervical cancer survivor

Screening

Eligibility

Sex/Gender

Female

Age

20 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Patients who were diagnosed with cervical cancer stage I-IVA at age between 20 and 70 years. 2. Patients who had been treated with standard treatment more than 3 months (not exceed than 10 years). 3. Patients did not have a cervical cancer recurrence. 4. Patients who were able to read and understand the questionnaire.

Exclusion criteria

Exclusion criteria: 1. Patients who had a history of other cancers.

Design outcomes

Primary

Measure	Time frame
Prevalence and Predictor of fear of cancer recurrence post complete treatment more than 3 months (not exceed than 10 years) the short version of the Fear of Progression Questionnaire	—

Secondary

Measure	Time frame
prevalence of anxiety and depression, and quality of life post complete treatment more than 3 months (not exceed than 10 years) the Hospital Anxiety and Depression Scale and the Functional Assessment of Cancer Therapy-Cervix	—

Countries

Thailand

Contacts

Public ContactJitti Hanprasertpong

Prince of Songkla University

hjitti@yahoo.com667-442-9617

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026